Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ranheim Dyreklinikk AS
AS
Active
Org 919449705
Vikelvfaret 4, 7054
Ranheim
Veterinary activities
·
NACE 7500
Est. 2017 · 8 years old
19 employees
www.ranheimdyreklinikk.no
Monitor
Share
Norway
/
Companies
/
Veterinary activities
/
Ranheim Dyreklinikk AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
22M
17M
11M
6M
0M
2021: 13M
13M
2021
2022: 15M (+15% vs 2021)
15M
+15%
2022
2023: 17M (+13% vs 2022)
17M
+13%
2023
2024: 18M (+6% vs 2023)
18M
+6%
2024
2025: 18M (0% vs 2024)
18M
0%
2025
EBITDA
NOK millions
7M
6M
4M
2M
0M
2021: 1M
1M
2021
2022: 2M (+100% vs 2021)
2M
+100%
2022
2023: 3M (+50% vs 2022)
3M
+50%
2023
2024: 4M (+33% vs 2023)
4M
+33%
2024
2025: 6M (+50% vs 2024)
6M
+50%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
18 218
17 657
17 131
14 696
12 742
Staff expenses
−6 103
−7 100
−6 799
−7 020
−5 846
EBITDA
6 168
4 458
3 239
1 657
1 243
Depreciation & amort.
−914
−573
−178
−172
−159
EBIT
5 255
3 884
3 061
1 485
1 084
Net financials
83
60
−38
−12
−0
Profit before tax
5 337
3 944
3 023
1 473
1 083
Tax
1 179
856
553
−0
−0
Net profit
4 159
3 088
2 470
1 473
1 083
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
7 842
6 031
3 691
4 326
2 844
Equity
48
30
30
−600
−2 073
Long-term debt
0
0
0
0
0
Short-term debt
7 794
6 001
3 661
4 926
4 917
Total debt
7 794
6 001
3 661
4 926
4 917
Financial ratios
5-year trend
EBITDA margin
33,9 %
This company
15,8 %
Market median
This company
Market median
115% above market
2021
2025
Equity ratio
0,6 %
This company
38,2 %
Market median
This company
Market median
98% below market
2021
2025
Return on equity
>999 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2021
2025
Net profit margin
22,8 %
This company
8,1 %
Market median
This company
Market median
181% above market
2021
2025
Asset turnover
2,32×
This company
1,12×
Market median
This company
Market median
107% above market
2021
2025
Debt / equity
162,84×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ranheim Dyreklinikk AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
